Global Parkinson Disease Drug Market Growth (Status and Outlook) 2022-2028

  • receipt Report ID : 322741
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 144
  • list Pharmaceuticals and Healthcare
Buy @ $3660

As the global economy mends, the 2021 growth of Parkinson Disease Drug will have significant change from previous year. According to our latest study, the global Parkinson Disease Drug market size is USD million in 2022 from USD 5372.5 million in 2021, with a change of % between 2021 and 2022. The global Parkinson Disease Drug market size will reach USD 8289.7 million in 2028, growing at a CAGR of 6.4% over the analysis period.

The United States Parkinson Disease Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Parkinson Disease Drug market, reaching US$ million by the year 2028. As for the Europe Parkinson Disease Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Parkinson Disease Drug players cover Merck, Akorn, GSK, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson Disease Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Bausch Health

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson Disease Drug Market Size 2017-2028

2.1.2 Parkinson Disease Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Parkinson Disease Drug Segment by Type

2.2.1 Sinemet-CR

2.2.2 Trastal

2.2.3 Madopar

2.2.4 COMT Inhibitor

2.2.5 Other

2.3 Parkinson Disease Drug Market Size by Type

2.3.1 Parkinson Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

2.4 Parkinson Disease Drug Segment by Application

2.4.1 Under 40 Years Old

2.4.2 40-65 Years Old

2.4.3 Above 65 Years Old

2.5 Parkinson Disease Drug Market Size by Application

2.5.1 Parkinson Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

3 Parkinson Disease Drug Market Size by Player

3.1 Parkinson Disease Drug Market Size Market Share by Players

3.1.1 Global Parkinson Disease Drug Revenue by Players (2020-2022)

3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2020-2022)

3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson Disease Drug by Regions

4.1 Parkinson Disease Drug Market Size by Regions (2017-2022)

4.2 Americas Parkinson Disease Drug Market Size Growth (2017-2022)

4.3 APAC Parkinson Disease Drug Market Size Growth (2017-2022)

4.4 Europe Parkinson Disease Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Parkinson Disease Drug Market Size by Country (2017-2022)

5.2 Americas Parkinson Disease Drug Market Size by Type (2017-2022)

5.3 Americas Parkinson Disease Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson Disease Drug Market Size by Region (2017-2022)

6.2 APAC Parkinson Disease Drug Market Size by Type (2017-2022)

6.3 APAC Parkinson Disease Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Parkinson Disease Drug by Country (2017-2022)

7.2 Europe Parkinson Disease Drug Market Size by Type (2017-2022)

7.3 Europe Parkinson Disease Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson Disease Drug by Region (2017-2022)

8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Parkinson Disease Drug Market Forecast

10.1 Global Parkinson Disease Drug Forecast by Regions (2023-2028)

10.1.1 Global Parkinson Disease Drug Forecast by Regions (2023-2028)

10.1.2 Americas Parkinson Disease Drug Forecast

10.1.3 APAC Parkinson Disease Drug Forecast

10.1.4 Europe Parkinson Disease Drug Forecast

10.1.5 Middle East & Africa Parkinson Disease Drug Forecast

10.2 Americas Parkinson Disease Drug Forecast by Country (2023-2028)

10.2.1 United States Parkinson Disease Drug Market Forecast

10.2.2 Canada Parkinson Disease Drug Market Forecast

10.2.3 Mexico Parkinson Disease Drug Market Forecast

10.2.4 Brazil Parkinson Disease Drug Market Forecast

10.3 APAC Parkinson Disease Drug Forecast by Region (2023-2028)

10.3.1 China Parkinson Disease Drug Market Forecast

10.3.2 Japan Parkinson Disease Drug Market Forecast

10.3.3 Korea Parkinson Disease Drug Market Forecast

10.3.4 Southeast Asia Parkinson Disease Drug Market Forecast

10.3.5 India Parkinson Disease Drug Market Forecast

10.3.6 Australia Parkinson Disease Drug Market Forecast

10.4 Europe Parkinson Disease Drug Forecast by Country (2023-2028)

10.4.1 Germany Parkinson Disease Drug Market Forecast

10.4.2 France Parkinson Disease Drug Market Forecast

10.4.3 UK Parkinson Disease Drug Market Forecast

10.4.4 Italy Parkinson Disease Drug Market Forecast

10.4.5 Russia Parkinson Disease Drug Market Forecast

10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2023-2028)

10.5.1 Egypt Parkinson Disease Drug Market Forecast

10.5.2 South Africa Parkinson Disease Drug Market Forecast

10.5.3 Israel Parkinson Disease Drug Market Forecast

10.5.4 Turkey Parkinson Disease Drug Market Forecast

10.5.5 GCC Countries Parkinson Disease Drug Market Forecast

10.6 Global Parkinson Disease Drug Forecast by Type (2023-2028)

10.7 Global Parkinson Disease Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Merck

11.1.1 Merck Company Information

11.1.2 Merck Parkinson Disease Drug Product Offered

11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Merck Main Business Overview

11.1.5 Merck Latest Developments

11.2 Akorn

11.2.1 Akorn Company Information

11.2.2 Akorn Parkinson Disease Drug Product Offered

11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Akorn Main Business Overview

11.2.5 Akorn Latest Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Parkinson Disease Drug Product Offered

11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GSK Main Business Overview

11.3.5 GSK Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Parkinson Disease Drug Product Offered

11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Information

11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered

11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Boehringer Ingelheim Main Business Overview

11.5.5 Boehringer Ingelheim Latest Developments

11.6 Teva Pharmaceutical

11.6.1 Teva Pharmaceutical Company Information

11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered

11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Teva Pharmaceutical Main Business Overview

11.6.5 Teva Pharmaceutical Latest Developments

11.7 Abbvie

11.7.1 Abbvie Company Information

11.7.2 Abbvie Parkinson Disease Drug Product Offered

11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Abbvie Main Business Overview

11.7.5 Abbvie Latest Developments

11.8 Kyowa Hakko Kirin Pharma

11.8.1 Kyowa Hakko Kirin Pharma Company Information

11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered

11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview

11.8.5 Kyowa Hakko Kirin Pharma Latest Developments

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Information

11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered

11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Astellas Pharma Main Business Overview

11.9.5 Astellas Pharma Latest Developments

11.10 Desitin Arzneimittel

11.10.1 Desitin Arzneimittel Company Information

11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered

11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Desitin Arzneimittel Main Business Overview

11.10.5 Desitin Arzneimittel Latest Developments

11. Endo Pharmaceuticals

11.11.1 Endo Pharmaceuticals Company Information

11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered

11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Endo Pharmaceuticals Main Business Overview

11.11.5 Endo Pharmaceuticals Latest Developments

11.12 F.Hoffmann-La Roche

11.12.1 F.Hoffmann-La Roche Company Information

11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered

11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 F.Hoffmann-La Roche Main Business Overview

11.12.5 F.Hoffmann-La Roche Latest Developments

11.13 H.Lundbeck

11.13.1 H.Lundbeck Company Information

11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered

11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 H.Lundbeck Main Business Overview

11.13.5 H.Lundbeck Latest Developments

11.14 Valeant

11.14.1 Valeant Company Information

11.14.2 Valeant Parkinson Disease Drug Product Offered

11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Valeant Main Business Overview

11.14.5 Valeant Latest Developments

11.15 Apokyn

11.15.1 Apokyn Company Information

11.15.2 Apokyn Parkinson Disease Drug Product Offered

11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Apokyn Main Business Overview

11.15.5 Apokyn Latest Developments

11.16 Orion

11.16.1 Orion Company Information

11.16.2 Orion Parkinson Disease Drug Product Offered

11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Orion Main Business Overview

11.16.5 Orion Latest Developments

11.17 Stada Arzneimittel

11.17.1 Stada Arzneimittel Company Information

11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered

11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Stada Arzneimittel Main Business Overview

11.17.5 Stada Arzneimittel Latest Developments

11.18 US WorldMeds

11.18.1 US WorldMeds Company Information

11.18.2 US WorldMeds Parkinson Disease Drug Product Offered

11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 US WorldMeds Main Business Overview

11.18.5 US WorldMeds Latest Developments

11.19 Bausch Health

11.19.1 Bausch Health Company Information

11.19.2 Bausch Health Parkinson Disease Drug Product Offered

11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Bausch Health Main Business Overview

11.19.5 Bausch Health Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Parkinson Disease Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Sinemet-CR

Table 3. Major Players of Trastal

Table 4. Major Players of Madopar

Table 5. Major Players of COMT Inhibitor

Table 6. Major Players of Other

Table 7. Parkinson Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

Table 10. Parkinson Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

Table 13. Global Parkinson Disease Drug Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Parkinson Disease Drug Revenue Market Share by Player (2020-2022)

Table 15. Parkinson Disease Drug Key Players Head office and Products Offered

Table 16. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Parkinson Disease Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Parkinson Disease Drug Market Size Market Share by Regions (2017-2022)

Table 21. Americas Parkinson Disease Drug Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Parkinson Disease Drug Market Size Market Share by Country (2017-2022)

Table 23. Americas Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

Table 25. Americas Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

Table 27. APAC Parkinson Disease Drug Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Parkinson Disease Drug Market Size Market Share by Region (2017-2022)

Table 29. APAC Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

Table 31. APAC Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

Table 33. Europe Parkinson Disease Drug Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Parkinson Disease Drug Market Size Market Share by Country (2017-2022)

Table 35. Europe Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

Table 37. Europe Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Parkinson Disease Drug Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Parkinson Disease Drug

Table 46. Key Market Challenges & Risks of Parkinson Disease Drug

Table 47. Key Industry Trends of Parkinson Disease Drug

Table 48. Global Parkinson Disease Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Parkinson Disease Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Parkinson Disease Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Parkinson Disease Drug Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Parkinson Disease Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Parkinson Disease Drug Market Size Market Share Forecast by Application (2023-2028)

Table 54. Merck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 55. Merck Parkinson Disease Drug Product Offered

Table 56. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Merck Main Business

Table 58. Merck Latest Developments

Table 59. Akorn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 60. Akorn Parkinson Disease Drug Product Offered

Table 61. Akorn Main Business

Table 62. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Akorn Latest Developments

Table 64. GSK Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 65. GSK Parkinson Disease Drug Product Offered

Table 66. GSK Main Business

Table 67. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. GSK Latest Developments

Table 69. Novartis Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 70. Novartis Parkinson Disease Drug Product Offered

Table 71. Novartis Main Business

Table 72. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Novartis Latest Developments

Table 74. Boehringer Ingelheim Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 75. Boehringer Ingelheim Parkinson Disease Drug Product Offered

Table 76. Boehringer Ingelheim Main Business

Table 77. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Boehringer Ingelheim Latest Developments

Table 79. Teva Pharmaceutical Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 80. Teva Pharmaceutical Parkinson Disease Drug Product Offered

Table 81. Teva Pharmaceutical Main Business

Table 82. Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Teva Pharmaceutical Latest Developments

Table 84. Abbvie Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 85. Abbvie Parkinson Disease Drug Product Offered

Table 86. Abbvie Main Business

Table 87. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Abbvie Latest Developments

Table 89. Kyowa Hakko Kirin Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 90. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered

Table 91. Kyowa Hakko Kirin Pharma Main Business

Table 92. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Kyowa Hakko Kirin Pharma Latest Developments

Table 94. Astellas Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 95. Astellas Pharma Parkinson Disease Drug Product Offered

Table 96. Astellas Pharma Main Business

Table 97. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Astellas Pharma Latest Developments

Table 99. Desitin Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 100. Desitin Arzneimittel Parkinson Disease Drug Product Offered

Table 101. Desitin Arzneimittel Main Business

Table 102. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Desitin Arzneimittel Latest Developments

Table 104. Endo Pharmaceuticals Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 105. Endo Pharmaceuticals Parkinson Disease Drug Product Offered

Table 106. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Endo Pharmaceuticals Main Business

Table 108. Endo Pharmaceuticals Latest Developments

Table 109. F.Hoffmann-La Roche Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 110. F.Hoffmann-La Roche Parkinson Disease Drug Product Offered

Table 111. F.Hoffmann-La Roche Main Business

Table 112. F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. F.Hoffmann-La Roche Latest Developments

Table 114. H.Lundbeck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 115. H.Lundbeck Parkinson Disease Drug Product Offered

Table 116. H.Lundbeck Main Business

Table 117. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. H.Lundbeck Latest Developments

Table 119. Valeant Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 120. Valeant Parkinson Disease Drug Product Offered

Table 121. Valeant Main Business

Table 122. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Valeant Latest Developments

Table 124. Apokyn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 125. Apokyn Parkinson Disease Drug Product Offered

Table 126. Apokyn Main Business

Table 127. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Apokyn Latest Developments

Table 129. Orion Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 130. Orion Parkinson Disease Drug Product Offered

Table 131. Orion Main Business

Table 132. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Orion Latest Developments

Table 134. Stada Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 135. Stada Arzneimittel Parkinson Disease Drug Product Offered

Table 136. Stada Arzneimittel Main Business

Table 137. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Stada Arzneimittel Latest Developments

Table 139. US WorldMeds Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 140. US WorldMeds Parkinson Disease Drug Product Offered

Table 141. US WorldMeds Main Business

Table 142. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. US WorldMeds Latest Developments

Table 144. Bausch Health Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 145. Bausch Health Parkinson Disease Drug Product Offered

Table 146. Bausch Health Main Business

Table 147. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Bausch Health Latest Developments

List of Figures

Figure 1. Parkinson Disease Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Parkinson Disease Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Parkinson Disease Drug Market Size Market Share by Type in 2021

Figure 7. Parkinson Disease Drug in Under 40 Years Old

Figure 8. Global Parkinson Disease Drug Market: Under 40 Years Old (2017-2022) & ($ Millions)

Figure 9. Parkinson Disease Drug in 40-65 Years Old

Figure 10. Global Parkinson Disease Drug Market: 40-65 Years Old (2017-2022) & ($ Millions)

Figure 11. Parkinson Disease Drug in Above 65 Years Old

Figure 12. Global Parkinson Disease Drug Market: Above 65 Years Old (2017-2022) & ($ Millions)

Figure 13. Global Parkinson Disease Drug Market Size Market Share by Application in 2021

Figure 14. Global Parkinson Disease Drug Revenue Market Share by Player in 2021

Figure 15. Global Parkinson Disease Drug Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Parkinson Disease Drug Market Size 2017-2022 ($ Millions)

Figure 17. APAC Parkinson Disease Drug Market Size 2017-2022 ($ Millions)

Figure 18. Europe Parkinson Disease Drug Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Parkinson Disease Drug Market Size 2017-2022 ($ Millions)

Figure 20. Americas Parkinson Disease Drug Value Market Share by Country in 2021

Figure 21. Americas Parkinson Disease Drug Consumption Market Share by Type in 2021

Figure 22. Americas Parkinson Disease Drug Market Size Market Share by Application in 2021

Figure 23. United States Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Parkinson Disease Drug Market Size Market Share by Region in 2021

Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Application in 2021

Figure 29. China Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Parkinson Disease Drug Market Size Market Share by Country in 2021

Figure 36. Europe Parkinson Disease Drug Market Size Market Share by Type in 2021

Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Application in 2021

Figure 38. Germany Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application in 2021

Figure 46. Egypt Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 52. APAC Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 53. Europe Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 55. United States Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 56. Canada Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 59. China Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 60. Japan Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 61. Korea Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 63. India Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 64. Australia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 65. Germany Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 66. France Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 67. UK Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 68. Italy Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 69. Russia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 70. Spain Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 73. Israel Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Parkinson Disease Drug Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Parkinson Disease Drug Market Size 2023-2028 ($ Millions)